San Mateo, CA, United States of America

Philip Worboys

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Philip Worboys

Introduction

Philip Worboys is an accomplished inventor based in San Mateo, California. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of treatments for serious infections. His work has had a notable impact on medical practices and patient care.

Latest Patents

Worboys holds a patent for "Doses and methods for administering telavancin." This patent outlines the administration of telavancin or its pharmaceutically-acceptable salts to human patients suffering from infections such as bacteremia, pneumonia, endocarditis, osteomyelitis, prosthetic joint infections, or complicated skin and skin structure infections. The patent also details methods for determining the appropriate dosage of telavancin based on the patient's weight and creatinine clearance.

Career Highlights

Throughout his career, Philip Worboys has worked with notable companies in the pharmaceutical industry. He has been associated with Cumberland Pharmaceuticals, Inc. and Theravance Biopharma Antibiotics IP, LLC. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.

Collaborations

Worboys has collaborated with esteemed colleagues, including Steven L. Barriere and Arthur Lo. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Philip Worboys is a prominent inventor whose work in the field of pharmaceuticals has led to significant advancements in treating serious infections. His patent for telavancin administration exemplifies his commitment to improving patient outcomes through innovative medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…